United States
Germany
Japan
United Kingdom
China
Nrf2 (NFE2L2) (NM_006164) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC204140L2V
- LentiORF®
-
Lenti ORF particles, NFE2L2 (mGFP-tagged) - Human nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
Product images
CNY 1,999.00
CNY 2,700.00
Specifications
| Product Data | |
| Product Name | Nrf2 (NFE2L2) (NM_006164) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | HEBP1; IMDDHH; Nrf-2; NRF2 |
| Vector | pLenti-C-mGFP |
| ACCN | NM_006164 |
| ORF Size | 1815 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC204140).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_006164.2 |
| RefSeq Size | 2859 bp |
| RefSeq ORF | 1818 bp |
| Locus ID | 4780 |
| Domains | BRLZ |
| Protein Families | Transcription Factors |
| MW | 67.8 kDa |
| Gene Summary | This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015] |
Documents
| Product Manuals |
| FAQs |
| SDS |
